Gelonghui August 7?605033.SH announced that on August 4th, 2023, the company received a letter from the Shanghai Stock Exchange ("SSE") concerning the examination of the application document for the issuance of convertible corporate bonds by Shaanxi Meibang Pharmaceutical Group Co., Ltd. to an unspecified object (SSE (refinancing) No. 2023). The audit body of the Shanghai Stock Exchange reviewed the application documents submitted by the company to issue convertible corporate bonds to unspecified targets and formed the first round of inquiry questions.
In accordance with the requirements of the inquiry letter, the company will implement and reply with the relevant intermediary agencies item by item, disclose the contents of the reply, and submit the relevant documents through the listing examination business system of Shanghai Stock Exchange.